FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PE3PSY0

Market Closed - Deutsche Boerse AG 03:50:25 2024-06-19 pm EDT
1.44 EUR -5.26% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-12.20%
1 month-15.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-19 1.44 -5.26%
24-06-18 1.52 -3.80%
24-06-17 1.58 -0.63%
24-06-14 1.59 0.00%
24-06-13 1.59 +3.92%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 03:50 pm EDT

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE3PSY
ISINDE000PE3PSY0
Date issued 2022-06-02
Strike 348.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 17.06
Lowest since issue 1.31
Spread 0.21
Spread %12.80%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus